Voltran Phototherapy System is an innovative soft laser therapy device specially developed for intranasal phototherapy, providing an effective and noninvasive solution for seasonal and perennial allergic rhinitis. Operating at 630 nm wavelength, Voltran targets the nasal mucosa to alleviate common symptoms of allergic reactions—such as sneezing, nasal congestion, itching, and watery eyes—while reducing reliance on long-term medications or invasive treatments.
Technology and Mechanism of Action
630 nm Soft Laser
- Specific Wavelength: Focuses on the nasal mucosa, facilitating localized photo-biomodulation and diminishing allergic responses.
- Painless Application: Generates no heat sensation or tissue damage, ensuring a comfortable patient experience during each 5-minute session.
Photobiomodulation in the Nasal Mucosa
- Histamine Release Prevention: Soft laser influences immune cells (mast cells, T lymphocytes, and eosinophils) to reduce histamine production and release, limiting allergic inflammation.
- Immunological Effects: Decreases the levels of eosinophils, ECP, Interleukin-5, and other mediators in nasal secretions—improving nasal symptoms and overall quality of life.
Ergonomic & Easy-to-Use Design
- Intranasal Probes: Engineered for quick, accurate positioning within the nostrils, distributing coherent light directly to the nasal mucosa.
- User-Friendly Interface: Guides practitioners or patients through simplified steps, ensuring straightforward operation while maintaining patient safety.
临床优势
Effective for Seasonal & Perennial Allergic Rhinitis
- Rapid Symptom Relief: Many patients observe improvement in sneezing, nasal discharge, itching, and congestion after only a few sessions.
- Year-Round Benefit: Controls symptoms triggered by pollen, dust mites, mold, or other perennial allergens.
Complementary or Standalone Therapy
- Reduced Medication Dependency: Ideal for individuals who cannot tolerate standard allergy medications or experience side effects and wish to minimize long-term drug use.
- Outpatient Use: Sessions are typically 5 minutes in duration, allowing convenient scheduling without extended hospital stays.
Painless & Minimally Invasive
- No Thermal Damage: Despite its laser-based origin, the 630 nm soft laser does not heat tissues or induce pain.
- No Bleeding or Tissue Trauma: The device neither physically disrupts mucosal surfaces nor requires incisions.
Long-Term Safety
- No Permanent Tissue Damage: Soft laser therapy exerts no harmful cumulative impact on nasal mucosa, suitable for repeated use in chronic allergic rhinitis management.
- Immunomodulatory Effects: Photo-biomodulation can help stabilize nasal immune response over multiple treatments.
Patient Selection & Considerations
理想候选人
- Refractory Allergic Rhinitis: Patients not adequately controlled by nasal sprays or oral antihistamines.
- Contraindications with Standard Therapies: Those experiencing medication side effects or interactions.
- Preference for Nonpharmacological Options: Individuals seeking minimal medication usage.
- Contraindications with Standard Therapies: Those experiencing medication side effects or interactions.
Exclusion Criteria
- Severe Structural Nasal Obstructions: Deviated septum or significant anatomical anomaly preventing device probe placement.
- Acute Viral/Bacterial Infections: Infections requiring standard treatments prior to phototherapy consideration.
- Tumors or Significant Nasopharyngeal Abnormalities: Risk of overshadowing or misinterpretation of therapy results.
- Severe Nasal Dryness or Crusting: Could complicate device insertion or hamper therapy comfort.
- Pacemakers or Cochlear Implants: In certain cases, electromagnetic considerations may preclude laser usage (verify local guidelines).
- Acute Viral/Bacterial Infections: Infections requiring standard treatments prior to phototherapy consideration.
相关产品
-
GuideX 加长导管
阅读更多一个 延长 或提供 "母子 "导管 强化支持 和 达到 在曲折或 远端 冠状动脉/外周段,实现稳定的设备导航。
-
Hero 机械除铅系统
阅读更多A 机械 替代品 铅提取使用专门的锁定插针或护套,以便 去除 纤维化附着物,确保 稳重 牵引力,以便安全移除。
-
Atlas Endovascular Peripheral Stent Graft
阅读更多A covered peripheral stent graft offering 巩 occlusion of aneurysms or occlusive lesions in iliac 或 femoral segments, reducing risk of rupture or re-occlusion.
-
Atlas Peripheral Stent System
阅读更多A robust peripheral stent platform designed for femoral, iliac或 popliteal lesions, ensuring adequate 径向支撑和 low restenosis rates in PAD interventions.